Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Swedish tick study aims to uncover hidden health threats

NCT ID NCT06781008

Knowledge-focused Sponsor: Region Jönköping County Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 600 children and adults in Sweden who may have tick-borne diseases. Researchers will monitor their health over six months to better understand symptoms, improve diagnosis, and develop clearer treatment guidelines. The goal is to help doctors manage these infections more effectively.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could lead to better diagnostic tools and treatment guidelines for tick-borne diseases in Sweden.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may not apply to other regions or tick species.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2023

Expected to finish

Dec 2035

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1. Medical history: tick exposure, tick bite, splenectomy, immunosuppressive treatment (e.g. anti-CD20 or other biological/immunomodulatory drugs, cortisone corresponding to \>10 mg prednisolone/day, chemotherapy, hematologic malignancy, other malignancy, rheumatologic disease) 2. Symptoms/clinical signs: fever after tick bite, relapsing fever of unknown origin, skin rashes (single/multiple erythema migrans, lymphocytoma, acrodermatitis chronica atrophicans or other), venous thrombosis, repeated thrombophlebitis, meningitis, encephalitis, myelitis, cranial nerve palsy, radiculitis, peripheral nerve involvment, mono-/oligoarthritis, carditis, ocular or otogenic disturbances of uncertain origin where medical history includes recent tick bite. 3. Biochemical findings in combination with factors under a) and b): leukopenia, thrombocytopenia, anemia, elevated liver enzymes, slightly elevated erythrocyte sedimentation rate and/or C-reactive protein, pleocytosis in CSF or synovial fluid.

Ages

1 year and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria in TBD and Non-TBD groups: * Clinical suspicion of tick-borne disease (physician's assessment based on medical history, symptoms, clinical findings and sometimes laboratory results) Exclusion Criteria: * Incapacitated to understand the study information and make decisions (adults and adolescents \>15 years)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Tick-borne diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

tick-borne infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Tick-borne diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Infectious Diseases

    NOT_YET_RECRUITING

    Uppsala, Region Uppsala, Sweden

  • Department of Infectious Diseases, County Hospital Ryhov

    RECRUITING

    Jönköping, Region Jönköping County, 55185, Sweden

  • Department of Infectious Diseases, Kalmar County Hospital

    RECRUITING

    Kalmar, Region Kalmar County, 392 56, Sweden

  • Department of Infectious Diseases, Linköping University Hospital

    RECRUITING

    Linköping, Region Östergötland, 581 85, Sweden

  • Department of Infectious Diseases, Vrinnevi Hospital

    RECRUITING

    Norrköping, Region Östergötland, 603 79, Sweden

  • Department of Paediatrics

    RECRUITING

    Falun, Region Dalarna, Sweden

  • Department of Paediatrics

    RECRUITING

    Jönköping, Region Jönköping County, 55185, Sweden

  • Department of Paediatrics

    NOT_YET_RECRUITING

    Uppsala, Region Uppsala, Sweden

  • Department of Paediatrics

    NOT_YET_RECRUITING

    Örebro, Region Örebro County, Sweden

  • Department of Paediatrics

    NOT_YET_RECRUITING

    Skövde, Västra Götalandsregionen, Sweden

  • Department of Paediatrics, Eksjö Hospital

    RECRUITING

    Eksjö, Region Jönköping County, 575 81, Sweden

  • Department of Paediatrics, Vrinnevi Hospital

    RECRUITING

    Norrköping, Region Östergötland, 603 79, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.